We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Screening Strategy Reduces Incidence of Immigration-Related Tuberculosis

By LabMedica International staff writers
Posted on 29 Mar 2015
Print article
Image: Mycobacterium tuberculosis culture revealing this organism’s typical morphologic characteristics of colorless rough surface, which are seen in M. tuberculosis colonial growth (Photo courtesy of Dr. George Kubica).
Image: Mycobacterium tuberculosis culture revealing this organism’s typical morphologic characteristics of colorless rough surface, which are seen in M. tuberculosis colonial growth (Photo courtesy of Dr. George Kubica).
Implementation of the culture-based algorithm may have substantially reduced the incidence of tuberculosis (TB) among newly arrived, foreign-born persons in the United States of America.

Immigration has a substantial effect on the incidence of TB, so immigrants and refugees bound for the USA are required to have overseas TB screening. Before 2007, a smear-based algorithm that could not diagnose smear-negative/culture-positive TB was used to screen this population.

Scientists at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) revised the screening strategy to use a more inclusive culture-based algorithm. They reviewed health records to determine the increase of smear-negative/culture-positive Mycobacterium tuberculosis or TB cases diagnosed overseas between 2007 and 2012 and compared that figure with the decline of reported TB cases among foreign-born persons within one year after arrival in the USA.

Of the 3,212,421 arrivals of immigrants and refugees from 2007 to 2012, a total of 1,650,961 (51.4%) were screened by the smear-based algorithm and 1,561,460 (48.6%) were screened by the culture-based algorithm. Among the 4,032 TB cases diagnosed by the culture-based algorithm, 2,195 (54.4%) were smear-negative/culture-positive. Before implementation (2002 to 2006), the annual number of reported cases among foreign-born persons within one year after arrival was relatively constant (range, 1,424 to 1,626 cases; mean, 1,504 cases), but decreased from 1,511 to 940 cases during implementation (2007 to 2012). During the same period, the annual number of smear-negative/culture-positive TB cases diagnosed overseas among immigrants and refugees bound for the USA by the culture-based algorithm increased from 4 to 629.

The authors concluded that the increased annual number of TB cases detected in immigrants and refugees closely matched in magnitude a decrease in the number reported TB cases, suggesting that the culture-based algorithm effectively reduced TB incidence. To further reduce the TB incidence in foreign-born populations, consideration should be given to expanding TB screening to students, exchange visitors, and temporary workers from countries with a high incidence of TB, as well as finding novel strategies to address the large numbers of foreign-born persons with latent TB infection The study was published on March 17, 2015, in the journal Annals of Internal Medicine.

Related Links:

[US] Centers for Disease Control and Prevention


New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.